Literature DB >> 26053720

18F-FDG PET/CT Follow-up of Rosai-Dorfman Disease.

Domenico Albano1, Giovanni Bosio, Francesco Bertagna.   

Abstract

Rosai-Dorfman disease (RDD) or sinus histiocytosis is a rare histiocytic disorder characterized by massive lymphadenopathy and with extranodal involvement in 25% to 43% of cases. The clinical course of RDD is unpredictable with episodes of exacerbation and remissions that can last many years, and treatment strategies can be different according to organ involvement. We report a case of a 42-year-old woman with extranodal disease followed for almost 10 years from the diagnosis who underwent seven (18)F-FDG PET/CT. PET/CT has proven to be a useful method for the management of this patient, mainly for the staging, follow-up, and evaluation of treatment results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053720     DOI: 10.1097/RLU.0000000000000853

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  16 in total

1.  Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosis.

Authors:  Domenico Albano; Giovanni Bosio; Raffaele Giubbini; Francesco Bertagna
Journal:  Jpn J Radiol       Date:  2017-07-26       Impact factor: 2.374

Review 2.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

3.  Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up.

Authors:  Sonia Mahajan; Reiko Nakajima; Mariko Yabe; Ahmet Dogan; Gary A Ulaner; Joachim Yahalom; Ariela Noy; Eli L Diamond; Heiko Schöder
Journal:  Clin Nucl Med       Date:  2020-06       Impact factor: 7.794

Review 4.  Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging.

Authors:  Ali Gholamrezanezhad; Kyle Basques; Ali Batouli; George Matcuk; Abass Alavi; Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2018-06       Impact factor: 3.959

5.  FDG PET/CT in the Evaluation of a Rare Case of Multisystem Involvement in Newly Diagnosed Rosai-Dorfman-Destombes Disease.

Authors:  Ahmed Fathala; Jameela Edathodu; Nasir Bakshi
Journal:  Saudi J Med Med Sci       Date:  2021-04-29

Review 6.  Spectrum of [18F]FDG-PET/CT Findings in Benign Lymph Node Pathology.

Authors:  Merissa N Zeman; Clare Green; Esma A Akin
Journal:  Mol Imaging Biol       Date:  2021-01-29       Impact factor: 3.488

7.  18F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report.

Authors:  Joya Hadchiti; Francois G Kamar; Jean Abi Ghosn; Mohamad Haidar; Ahmad Younes; Antoine Obeid; Marwan Haddad; Fadi Farhat; Feras Chehade
Journal:  Mol Clin Oncol       Date:  2017-11-21

8.  Rosai-Dorfman disease: A case report of asymptomatic isolated renal involvement.

Authors:  Alireza Abrishami; Pardis Ziaeefar; Sara Ebrahimi; Nastaran Khalili; Akbar Nouralizadeh; Reza Farjad
Journal:  Clin Case Rep       Date:  2021-07-10

9.  18F-FDG PET/CT Imaging of Extranodal Rosai-Dorfman Disease with Hepatopancreatic Involvement - A Pictorial and Literature Review.

Authors:  Faiq Shaikh; Omer Awan; Sohaib Mohiuddin; Saleem Farooqui; Salman A Khan; William McCartney
Journal:  Cureus       Date:  2015-12-03

10.  Multimodality imaging-based evaluation of Rosai-Dorfman disease in the head and neck: A retrospective observational study.

Authors:  Qinggang Xu; Liping Fu; Chengyao Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.